Q2 2026 13F · SEC CIK 1834239
EQT Fund Management S.a r.l.
Hedge fundFiled 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $862.6M
- Reported positions
- 5
- Holdings vs S&P 500, 3 yrs
- —
- Average holding period
- 2 qtrs
EQT Fund Management S.a r.l. is a hedge fund that reported 5 positions worth $862.6M in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Waystar Hldg Corp (WAY, 59.2%), Pharvaris N V (PHVS, 13.7%), Oculis Holding AG (OCS, 11.2%).
EQT Fund Management S.a r.l. holdings all 5 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| WAYWaystar Hldg Corp | 59.2% | +0.0% | $510.8M |
| PHVSPharvaris N V | 13.7% | +0.0% | $118.4M |
| OCSOculis Holding AG | 11.2% | +17.8% | $96.4M |
| EVMNEvommune Inc | 8.1% | +7.3% | $70.3M |
| AGMBAgomab Therapeutics NV | 7.7% | +0.0% | $66.7M |
What EQT Fund Management S.a r.l. bought and sold in Q2 2026, against Q1 2026.
New positions
No new positions among the largest holdings.
Added to
- OCS Oculis Holding AG+17.8% shares
- EVMN Evommune Inc+7.3% shares
Reduced
No position shrank by more than 5%.
Sold out
Nothing sold out.
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- —
- 3 years
- —
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $862.6M | 5 |
| Q1 2026 | $1.0B | 5 |
Questions about EQT Fund Management S.a r.l.'s portfolio
What stocks does EQT Fund Management S.a r.l. own?
EQT Fund Management S.a r.l.'s latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 5 positions worth $862.6M. The largest are Waystar Hldg Corp (WAY) at 59.2%, Pharvaris N V (PHVS) at 13.7%, Oculis Holding AG (OCS) at 11.2%, Evommune Inc (EVMN) at 8.1% and Agomab Therapeutics NV (AGMB) at 7.7%.
What did EQT Fund Management S.a r.l. buy last quarter?
In Q2 2026, EQT Fund Management S.a r.l. added Oculis Holding AG (OCS) (+17.8% shares) and Evommune Inc (EVMN) (+7.3% shares), compared with its Q1 2026 filing.
What did EQT Fund Management S.a r.l. sell last quarter?
EQT Fund Management S.a r.l. sold out of nothing and cut no large position by more than 5% in Q2 2026.
When is EQT Fund Management S.a r.l.'s next 13F filing due?
13F filings are due 45 days after each quarter ends. EQT Fund Management S.a r.l.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.